Skip to main content
Top
Published in: Gastric Cancer 2/2013

01-04-2013 | Original Article

Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population

Authors: Hye-Rim Song, Min-Ho Shin, Hee Nam Kim, Jin-Mei Piao, Jin-Su Choi, Jun-Eul Hwang, Young-Kyu Park, Dong-Wook Ryang, Duck Cho, Sun-Seog Kweon

Published in: Gastric Cancer | Issue 2/2013

Login to get access

Abstract

Background

Although previous studies have demonstrated an association between ABO blood group and the risk of gastric cancer (GC), only one study has identified these associations using the ABO genotype; however, that study did not evaluate sex differences in this association. The aim of the present study was to investigate whether there are sex-specific differences in the ABO genotype-associated risk of GC. In addition, we explored the association of the ABO genotype and the clinicopathologic characteristics of GC in a Korean population.

Methods

We conducted a large-scale case–control study of 3245 GC patients (2204 males, 1041 females) and 1700 controls (821 males, 879 females). The ABO genotype was determined by multicolor real-time polymerase chain reaction (PCR) using displacing probes.

Results

As compared with genotype OO, genotypes AA and AO in females, but not in males, were associated with a significantly increased risk of GC (odds ratio [OR] 1.56 and 95 % confidence interval [CI] 1.08–2.26 for AA; OR 1.57 and 95 % CI 1.21–2.03 for AO). In a subgroup analysis, blood group A had a significantly increased risk of diffuse-type GC (OR 2.00, 95 % CI 1.43–2.78), but not of intestinal-type (OR 1.31, 95 % CI 0.96–1.79) or mixed-type GC (OR 1.43, 95 % CI 0.92–2.24).

Conclusion

The ABO genotypes AA and AO were significantly associated with GC only in females and only for diffuse-type GC. These data suggest that the association between ABO blood group and GC risk may differ according to sex and histological type.
Literature
1.
go back to reference Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011;43(1):1–11.PubMedCrossRef Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011;43(1):1–11.PubMedCrossRef
2.
go back to reference Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–62.PubMed Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–62.PubMed
3.
go back to reference Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280–5.PubMedCrossRef Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280–5.PubMedCrossRef
4.
go back to reference Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1(4814):799–801.PubMedCrossRef Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1(4814):799–801.PubMedCrossRef
5.
8.
go back to reference Lissowska J, Groves FD, Sobin LH, Fraumeni JF Jr, Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev. 1999;8(3):223–7. Lissowska J, Groves FD, Sobin LH, Fraumeni JF Jr, Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev. 1999;8(3):223–7.
9.
go back to reference Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986–90.PubMedCrossRef Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986–90.PubMedCrossRef
10.
go back to reference Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and ABO blood group alleles: results from the Pancreatic Cancer Cohort Consortium. Cancer Res. 2010;70(3):1015–23.PubMedCrossRef Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and ABO blood group alleles: results from the Pancreatic Cancer Cohort Consortium. Cancer Res. 2010;70(3):1015–23.PubMedCrossRef
11.
go back to reference Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the Pancreatic Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3140–9.PubMedCrossRef Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the Pancreatic Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3140–9.PubMedCrossRef
12.
go back to reference Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, et al. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1665–72.PubMedCrossRef Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, et al. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1665–72.PubMedCrossRef
13.
go back to reference Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 2010;16(2):256–63.PubMedCrossRef Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol. 2010;16(2):256–63.PubMedCrossRef
14.
go back to reference Garcia-Esquinas E, Pérez-Gómez B, Pollán M, Boldo E, Fernández-Navarro P, Lope V, et al. Gastric cancer mortality trends in Spain, 1976–2005, differences by autonomous region and sex. BMC Cancer. 2009;9:346.PubMedCrossRef Garcia-Esquinas E, Pérez-Gómez B, Pollán M, Boldo E, Fernández-Navarro P, Lope V, et al. Gastric cancer mortality trends in Spain, 1976–2005, differences by autonomous region and sex. BMC Cancer. 2009;9:346.PubMedCrossRef
15.
go back to reference Su M, Lu SM, Tian DP, Zhao H, Li XY, Li DR, et al. Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol. 2001;7(5):657–61.PubMed Su M, Lu SM, Tian DP, Zhao H, Li XY, Li DR, et al. Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol. 2001;7(5):657–61.PubMed
16.
go back to reference Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol. 2008;140(3):287–94.PubMedCrossRef Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol. 2008;140(3):287–94.PubMedCrossRef
17.
go back to reference Cho D, Song HR, Won EJ, Shin DJ, Shin MH, Kwon SY, et al. Application of real-time PCR for ABO genotyping for large-scale population screening. Korean J Blood Transfus. 2011;22:110–9. Cho D, Song HR, Won EJ, Shin DJ, Shin MH, Kwon SY, et al. Application of real-time PCR for ABO genotyping for large-scale population screening. Korean J Blood Transfus. 2011;22:110–9.
18.
go back to reference Ruan L, Zhao H, Li Q. Multicolor real-time PCR genotyping of ABO system using displacing probes. J Forensic Sci. 2010;55(1):19–24.PubMedCrossRef Ruan L, Zhao H, Li Q. Multicolor real-time PCR genotyping of ABO system using displacing probes. J Forensic Sci. 2010;55(1):19–24.PubMedCrossRef
19.
go back to reference Cho D, Kim SH, Jeon MJ, Choi KL, Kee SJ, Shin MG, et al. The serological and genetic basis of the cis-AB blood group in Korea. Vox Sang. 2004;87(1):41–3.PubMedCrossRef Cho D, Kim SH, Jeon MJ, Choi KL, Kee SJ, Shin MG, et al. The serological and genetic basis of the cis-AB blood group in Korea. Vox Sang. 2004;87(1):41–3.PubMedCrossRef
20.
go back to reference Mizuno N, Ohmori T, Sekiguchi K, Kato T, Fujii T, Fujii K, et al. Alleles responsible for ABO phenotype-genotype discrepancy and alleles in individuals with a weak expression of A or B antigens. J Forensic Sci. 2004;49(1):21–8.PubMedCrossRef Mizuno N, Ohmori T, Sekiguchi K, Kato T, Fujii T, Fujii K, et al. Alleles responsible for ABO phenotype-genotype discrepancy and alleles in individuals with a weak expression of A or B antigens. J Forensic Sci. 2004;49(1):21–8.PubMedCrossRef
21.
go back to reference Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB, et al. ABO blood group and cancer. Eur J Cancer. 2010;46(18):3345–50.PubMedCrossRef Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB, et al. ABO blood group and cancer. Eur J Cancer. 2010;46(18):3345–50.PubMedCrossRef
22.
go back to reference Xie J, Qureshi AA, Li Y, Han J, et al. ABO blood group and incidence of skin cancer. PLoS One. 2010;5(8):e11972.PubMedCrossRef Xie J, Qureshi AA, Li Y, Han J, et al. ABO blood group and incidence of skin cancer. PLoS One. 2010;5(8):e11972.PubMedCrossRef
23.
go back to reference Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS, et al. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011;128(2):482–6.PubMedCrossRef Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS, et al. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011;128(2):482–6.PubMedCrossRef
24.
go back to reference Kanbay M, Gür G, Arslan H, Yilmaz U, Boyacioglu S, et al. The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci. 2005;50(7):1214–7.PubMedCrossRef Kanbay M, Gür G, Arslan H, Yilmaz U, Boyacioglu S, et al. The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci. 2005;50(7):1214–7.PubMedCrossRef
25.
go back to reference Wu TC, Chen LK, Hwang SJ. Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups. World J Gastroenterol. 2003;9(8):1752–5.PubMed Wu TC, Chen LK, Hwang SJ. Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups. World J Gastroenterol. 2003;9(8):1752–5.PubMed
26.
go back to reference Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56(1):1–9.PubMedCrossRef Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56(1):1–9.PubMedCrossRef
27.
go back to reference Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, et al. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol. 2007;60(3):273–7.PubMedCrossRef Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, et al. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol. 2007;60(3):273–7.PubMedCrossRef
Metadata
Title
Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population
Authors
Hye-Rim Song
Min-Ho Shin
Hee Nam Kim
Jin-Mei Piao
Jin-Su Choi
Jun-Eul Hwang
Young-Kyu Park
Dong-Wook Ryang
Duck Cho
Sun-Seog Kweon
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2013
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-012-0176-z

Other articles of this Issue 2/2013

Gastric Cancer 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.